ArticleNeuro-oncology2026
Corrigendum to: ΔNp73/ETS2 complex drives glioblastoma pathogenesis-targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.